People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elektrofi, Inc. | — | Biotechnology | Series D+ | $154.8M | $1.2B | 2024 |
Peter L. Bojo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter L. Bojo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Norris | 1 | 5 |
| Charles L. Cooney | 1 | 4 |
| Chase Coffman | 1 | 1 |
| Constantine L. Chinoporos | 1 | 1 |
| Arman L. Gupta | 1 | 1 |
| Noel L. Jee | 1 | 1 |
| Sam L. Huang | 1 | 1 |
| Constatine L. Chinoporos | 1 | 1 |
| Andrew L. Goldberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.